The Effect of Dietary Soy Supplementation on Hot Flushes

Albertazzi, Paola; Pansini, F.; Bonaccorsi, Gloria; Zanotti, Laura; Forini, Elena; Aloysio, Domenico De

doi:10.1016/s0029-7844(97)00597-8

Cited by 392 publications

(187 citation statements)

References 13 publications

Supporting

Mentioning

171

Contrasting

Unclassified

Order By: Relevance

“…It may be that the actual dietary content was higher, as another Australian study that provided the same supplement reported much higher urinary excretion (45 µmol/day) of DAI (86) than has been reported in other feeding studies (Table 8); however, the latter study did not observe any changes in vaginal cytology. Two more recent studies did not observe changes in vaginal cytology during soy supplementation (50,87).…”

Section: Proliferation Of Uterine and Vaginal Epitheliummentioning

confidence: 90%

Cross-species and interassay comparisons of phytoestrogen action.

Whitten

Patisaul

2001

Environ Health Perspect

174

105

View full text Add to dashboard Cite

This paper compiles animal and human data on the biologic effects and exposure levels of phytoestrogens in order to identify areas of research in which direct species comparisons can be made. In vitro and in vivo assays of phytoestrogen action and potency are reviewed and compared to actions, dose-response relationships, and estimates of exposure in human subjects. Binding studies show that the isoflavonoid phytoestrogens are high-affinity ligands for estrogen receptors (ERs), especially ER beta, but have lower potency in whole-cell assays, perhaps because of interactions with binding proteins. Many other enzymatic actions require concentrations higher than those normally seen in plasma. In vivo data show that phytoestrogens have a wide range of biologic effects at doses and plasma concentrations seen with normal human diets. Significant in vivoresponses have been observed in animal and human tests for bone, breast, ovary, pituitary, vasculature, prostate, and serum lipids. The doses reported to be biologically active in humans (0.4--10 mg/kg body weight/day) are lower than the doses generally reported to be active in rodents (10--100 mg/kg body weight/day), although some studies have reported rodent responses at lower doses. However, available estimates of bioavailability and peak plasma levels in rodents and humans are more similar. Steroidogenesis and the hypothalamic-pituitary-gonadal axis appear to be important loci of phytoestrogen actions, but these inferences must be tentative because good dose-response data are not available for many end points. The similarity of reported proliferative and antiproliferative doses illustrates the need for fuller examination of dose-response relationships and multiple end points in assessing phytoestrogen actions.

show abstract

Section: Proliferation Of Uterine and Vaginal Epitheliummentioning

confidence: 90%

Cross-species and interassay comparisons of phytoestrogen action.

Whitten

Patisaul

2001

Environ Health Perspect

174

105

View full text Add to dashboard Cite

show abstract

“…Isoflavones have weak estrogenic properties because of their structural similarity to 17␤-estradiol [10,11]. Accumulating evidence suggests beneficial influence of soy isoflavones on metabolic and gynecologic conditions in women [12][13][14]. Recent studies in postmenopausal women, further, indicate protective effects of isoflavones on lean tissue [15] and fat-free mass [16].…”

Section: Introductionmentioning

confidence: 99%

Legumes and soy products consumption and functional disability in older women

Kim

Lee

2011

Maturitas

View full text Add to dashboard Cite

“…However, the vaginal dryness score appeared to be more improved in the isoflavone-supplemented group compared with the control diet group 104 . The trial by Albertazzi et al 105 found significantly greater reductions in hot flush frequency and severity among isoflavone users.…”

Section: Climacteric Symptomsmentioning

confidence: 99%

Health potential of soy isoflavones for menopausal women

Anderson¹,

Anthony

Cline

et al. 1999

Public Health Nutr.

143

View full text Add to dashboard Cite

Objective: To review the current literature on the effects of soy isoflavones, one class of phyto-oestrogens, on cardiovascular diseases, osteoporosis, cancer and climacteric symptoms. Design: Many study designs were employed in the reports reviewed here, including prospective human trials, observational human studies, animal experiments and in vitro cell studies that explored the protective or preventive effects of soy isoflavones (genistein, daidzein and glycitein alone or mixed). Setting: Diverse settings were employed, depending on study design. Subjects: Human subjects, mostly menopausal or postmenopausal, were included, as were animal models and specific cell types. Results: The findings were: (i) isoflavones plus soy protein together were needed to obtain the highly significant beneficial results on blood lipids and arterial dimensions; (ii) isoflavone treatments alone at high doses (relative to above) consistently improved bone parameters in rodent ovariectomized models, but not in humans or primates; (iii) isoflavones were not consistent in exerting positive effects regarding the prevention or treatment of cancers of the mammary glands, uterus and colon; and (iv) the effects of isoflavones on climacteric symptoms were not clear-cut. Conclusions:The promise of soy isoflavones reducing chronic disease risk seems to be non-uniform, with the most conclusive benefits occurring in the prevention of cardiovascular diseases, but other organ systems, such as skeletal and reproductive tissues, may also benefit from the consumption of soy and soy-derived products. Phyto-oestrogenic molecules have received a great deal of attention over the last few years because of their potentially preventive roles against a few of today's most prevalent chronic diseases, namely, cardiovascular disease, osteoporosis and hormone-related cancers 1,2 . The particular plant molecules of interest are isoflavones, which are found in abundance in soybeans and their derivative foods, such as tofu, miso and others. Of the several isoflavones that are made by soybeans, genistein, in particular, has been experimentally shown to be the most efficacious in human subjects and animal models. For the last several years, a concerted effort has been mounted to identify alternatives to traditional hormone replacement therapy (HRT). Pharmaceutical companies have been developing selective oestrogen receptor modulators (SERMs), which ideally will provide the beneficial effects of oestrogen replacement for bones, cardiovascular system and cognitive function, without adverse effects on breast and endometrial cancer. As a result, SERMs should not require co-administration with a progestin, which can eliminate the side effects that some women experience with that hormone. The first molecules of this new class of drugs to become available are tamoxifen and raloxifene, which exhibit many, but not all, of the qualities of an ideal HRT. Many consumers would also prefer to avoid synthetic molecules in favour of natural products. Soy phytooestrogens, na...

show abstract

The Effect of Dietary Soy Supplementation on Hot Flushes

Abstract: Soy protein isolate added daily to the diet substantially reduced the frequency of hot flushes in climacteric women.

Cited by 392 publications

References 13 publications

Cross-species and interassay comparisons of phytoestrogen action.

Cross-species and interassay comparisons of phytoestrogen action.

Legumes and soy products consumption and functional disability in older women

Health potential of soy isoflavones for menopausal women

Contact Info

Product

Resources

About